Checking in on the Diagnostics sector with CG Senior Analyst Kyle Mikson, CFA

Join us for this lively discussion with CG Managing Director and Senior Analyst Kyle Mikson, CFA, as we explore the evolving life science research tools and healthcare diagnostics landscape, including a fresh look at the bioprocessing sector, and how Trump appointees may impact funding for the NIH.

Kyle Mikson, CFA, is a Managing Director and Senior Analyst covering the Medical Tools and Diagnostics sector here at CG. Kyle earned a BS in Biomedical Engineering from Case Western Reserve University and worked in a variety of industry and investment-related roles before joining CG in 2021. In this discussion, Kyle lays out the key growth vectors for Life Science Tools & Diagnostics as the sector broadens its capabilities beyond Proteomics and Genomics to incorporate Single Cell and Spatial Biology approaches. He also highlights his recent report on the Bioprocessing industry, an important companion sector to Tools & Diagnostics, and walks us through possible impacts to the entire value chain from the inbound Trump administration’s healthcare nominees.

Please visit https://www.canaccordgenuity.com/capital-markets/expertise/research-and-strategy/  for more details on Canaccord Genuity Research and send all inquiries to strategicinsights@cgf.com.

This content is for informational purposes only and should not be taken as legal, business, financial or investment advice. This content is not intended to promote any product or service of Canaccord Genuity.

The opinions and views expressed in this program may not necessarily reflect the institutional views of Canaccord Genuity or its affiliates. 

This program should not be copied, distributed, published, or reproduced in whole or in part without the expressed written consent of Canaccord Genuity. 

Certain information contained in this program constitutes forward looking statements and there is no guarantee that these results will be achieved. Canaccord Genuity has no obligation to provide updates or changes to the information in this program. Past performance does not guarantee future results which may vary. 

Canaccord Genuity LLC is a registered broker-dealer regulated by the SEC and FINRA. Member SIPC. Canaccord Genuity Corp. Member CIRO/Canadian Investor Protection Fund. Canaccord Genuity Limited, Authorized and Regulated by the Financial Conduct Authority, Member LSE. Offices in other countries are offices of other companies in the Canaccord Genuity group of companies.

Canaccord Genuity Research Disclosures are available at the following link: https://canaccordgenuity.bluematrix.com/sellside/Disclosures.action